WEIGHT-loss jabs are taking the world by storm, with a staggering half a million of us now using them. The injections have ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

STRUGGLING to keep up with her two young children and dreading her own reflection in the mirror, Emma Lasenby knew something ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with onli ...

This study provides valuable insight into the increasing use of obesity drugs. The rising prescription numbers suggest that ...

The names at the forefront of weight loss drugs are Eli Lilly, the U.S. manufacturer of Mounjaro and Zepbound; and Novo Nordisk, the Danish maker of Ozempic, Saxenda, and Wegovy. However ...

As a weight loss drug, semaglutide is intended to be used ... Zepbound (tirzepatide) and Saxenda (liraglutide) are two other options FDA-approved for weight management. It’s also possible ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...